Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Cancer prevention has advanced significantly, with some strategies proving successful.

Tadalafil and Finasteride may help treat aggressive melanoma.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.